Number of the records: 1
Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy
- 1.Šímová, J., Indrová, M., Bieblová, J., Mikyšková, R., Bubeník, J., Reiniš, M. Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy. International Journal of Cancer. 2010, 126(12), 2997-3004. ISSN 0020-7136. E-ISSN 1097-0215. Available: doi: 10.1002/ijc.24887
Number of the records: 1